Participations à des congrès et colloques internationaux (28)
  1. 16. Alexandri, C., Stamatopoulos, B., & Demeestere, I. (2016). MiRNAs involvement in cyclophosphamide-induced growing follicular damage in mice. Poster présenté à la conférence TELEVIE's Researchers Seminar (8/12/2016: Brussels, Belgium).
  2. 17. Alexandri, C., Stamatopoulos, B., & Demeestere, I. (2016). MiRNAs involvement in cyclophosphamide-induced growing follicular damage in mice. Poster présenté à la conférence VIII Ovarian Club Meeting (November 4-6, 2016: Paris, France).
  3. 18. Stamatopoulos, B., et al. (2016). IgHV gene mutation status by next-generation deep sequencing in CLL: prognostic significance of multiple subclones. Paper session presented at 31th annual general meeting of the Belgian Hematology Society (BHS) (January 2016: La Hulpe, Belgium).
  4. 19. Stamatopoulos, B., et al. (2015). DNA 5-hydroxymethylcytosine level, TET and IDH gene expression and prognosis significance in Chronic Lymphocytic Leukemia. Paper session presented at Chronic Lymphocytic Leukemia Young Investigators Meeting 2015 (September 2015: Sydney, Australia).
  5. 20. Stamatopoulos, B., et al. (2011). AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a microenvironment: preclinical evidence for its association with CLL treatments. Paper session presented at 11th International Conference on Malignant Lymphoma (ICML), (June 2011: Lugano, Switzerland).
  6. 21. Stamatopoulos, B., et al. (2010). The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces apoptosis, downregulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells. Paper session presented at 26th annual general meeting of the Belgian Hematology Society (BHS) (January 2010: Liège, Belgium).
  7. 22. Mascaux, C., Haibe-Kains, B., Anthoine, G., Rothé, F., Stamatopoulos, B., Desmedt, C., Haller, A., Ninane, V., Burny, A., & Sculier, J.-P. (2009). Evolution of biological pathways involved at successive steps of lung carcinogenesis. Poster présenté à la conférence AACR Annual Meeting (Apr 18-22, 2009: Denver, Colorado, USA).
  8. 23. Mascaux, C., Haibe-Kains, B., Anthoine, G., Rothé, F., Stamatopoulos, B., Desmedt, C., Laes, J.-F., Haller, A., Ninane, V., Burny, A., & Sculier, J.-P. (2009). Evolution of genomic profile during successive steps of lung squamous carcinogenesis. Poster présenté à la conférence Annual Meeting of the American Association for Cancer Research (AACR) (April 2009: Denver, CO, USA).
  9. 24. Stamatopoulos, B., et al. (2008). Gene expression profiles based on ZAP70 mRNA levels. Paper session presented at Scientific Workshop of the European Research Initiative on CLL (ERIC) (June 2008: Copenhagen, Denmark).
  10. 25. Stamatopoulos, B., et al. (2008). Microrna-29c and microrna-223 downregulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Paper session presented at Belgian Hematology Society (BHS) Annual General Meeting (January 2008: Ostende, Belgium).
  11. 26. Stamatopoulos, B., et al. (2008). Comparison of Chronic Lymphocytic Leukemia patients expressing high or low level of ZAP70 mRNA: new prognostic factors, differences in microRNA expression and interaction with the microenvironment. Paper session presented at 23rd annual general meeting of the Belgian Hematology Society (BHS) (January 2008: Ostende, Belgium).
  12. 27. Stamatopoulos, B., Meuleman, N., Haibe-Kains, B., Duvillier, H., Massy, M., Martiat, P., Bron, D., & Lagneaux, L. (2007). Chronic Lymphocytic Leukemia: which prognostic factor to choose? Poster présenté à la conférence International Workshop on Chronic Lymphocytic Leukemia (iwCLL) (12: 14-16 September 2007: London).
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>